NCT01527734View on ClinicalTrials.gov

Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2012

Conditions
Healthy
Interventions
DRUG

Tetrodotoxin

15ug and 30ug once or twice a day for 1 or 2 days.

DRUG

placebo

1ml once or twice a day for 1 or 2 days.

Trial Locations (1)

98418

Comprehensive Clinical Research, Tacoma

All Listed Sponsors
lead

Wex Pharmaceuticals Inc.

INDUSTRY

NCT01527734 - Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers | Biotech Hunter | Biotech Hunter